Skip to main content
Premium Trial:

Request an Annual Quote

DREAM, Sage Bionetworks Partner on Open Computational Challenges


Sage Bionetworks said this week that it will work with the organizers of the Dialogue for Reverse Engineering Assessment and Methods, or DREAM, to run open computational challenges focused on scientific discovery and clinical research.

As part of the collaboration, Sage's Synapse platform will be used to share data and code during computational challenges, while DREAM's organizers will contribute expertise they've gained from running 24 contests in the last five years, the partners said.

This partnership is a continuation of an existing relationship between Sage and the DREAM project. Last summer, they worked together on one of the challenges for the seventh incarnation of DREAM, which aimed to develop algorithms for predicting breast cancer survival (BI 6/15/2012).

The partners said that the merger will enable them run several challenges similar to the breast cancer prognosis challenge yearly and provide a collaborative framework for open science.

"Traditional ways of doing science [have] researchers too focused on being the first to publish," resulting in a "culture of secrecy about scientific results and data," Gustavo Stolovitzky, founder of the DREAM project, said in a statement.

"By refocusing our efforts on creating a collaborative research environment, DREAM and Sage Bionetworks can foster a complementary way of doing science," he said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.